Limited EvidenceNutraceutical3 products compared

Best Myo-Inositol Supplements for PCOS Support: Evidence-Based Rankings

Polycystic ovary syndrome affects an estimated 8–13% of reproductive-age women worldwide, and for many, the most disruptive symptoms — irregular periods, elevated androgens, stubborn weight gain, and blood sugar swings — trace back to a single underlying thread: insulin resistance. Conventional management typically involves lifestyle changes and, where appropriate, pharmaceutical interventions, but a growing number of women are asking whether nutritional approaches can play a meaningful supporting role. Myo-inositol has emerged as one of the most closely studied options in this space, and the research base, while still maturing, is more substantial than what exists for most supplements. Myo-inositol is a naturally occurring carbohydrate compound found in many foods and produced in small amounts by the body. It functions as a second messenger in several hormonal signaling pathways, including those triggered by insulin. In women with PCOS, tissue-level deficiencies in inositol signaling have been proposed as a contributing mechanism to insulin resistance, and supplementation may support the restoration of more normal signaling patterns. What distinguishes this page from a generic inositol review is the ratio question. Inositol is not a single compound — the two main dietary forms, myo-inositol (MI) and d-chiro-inositol (DCI), have different roles in the body, and research suggests that the ratio between them matters as much as the total dose. Products marketed simply as 'inositol' vary widely, and understanding why a 40:1 MI-to-DCI ratio has emerged as a research-supported target can help women make better-informed choices about which products are worth considering. This review aims to be honest about what the evidence does and does not show. Myo-inositol is not a treatment for PCOS and cannot prevent or cure any disease. The research suggests it may support metabolic and reproductive parameters in some women, but individual responses vary, and no supplement replaces a comprehensive care plan developed with a qualified healthcare provider. If you have PCOS, please discuss any supplementation decisions with your physician or a registered dietitian-nutritionist before starting.

Written by Editorial Team·Medically reviewed by Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950·Updated June 18, 2026·How we picked these products

This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement.

Why It Works

Key Benefits of Myo-Inositol for PCOS Support

Research suggests myo-inositol at a 40:1 ratio with d-chiro-inositol may support more regular menstrual cycling in some women with PCOS-related ovulatory dysfunction

Some studies indicate that the 40:1 MI:DCI combination may help support insulin sensitivity markers, including fasting insulin and HOMA-IR, in women with PCOS and concurrent insulin resistance

Evidence suggests myo-inositol supplementation may be associated with modest reductions in circulating androgen levels, which may contribute to improvements in androgen-related symptoms in some women

Research in women with PCOS undergoing assisted reproduction suggests inositol supplementation may support oocyte quality parameters, though this should always be discussed with a reproductive specialist

The 40:1 myo-inositol to d-chiro-inositol combination may offer a more physiologically aligned approach than myo-inositol or d-chiro-inositol supplementation alone, based on the ratio found in healthy follicular fluid

Our Picks

Best Myo-Inositol for PCOS Support in 2026

Ranked by quality, value, and clinical backing

Where available, we show when each product price was last checked so the list stays honest without overreacting to normal Amazon price movement.

🏆Best Overall

#1Editor's Choice

8.8

Theralogix

Ovasitol Inositol Supplement

4.6

$52.99/ $0.88 per serving

Ovasitol earns the top position primarily because it is the only product in this review that is NSF Certified, providing independent third-party verification of both label accuracy and manufacturing quality. It delivers the 40:1 myo-inositol to d-chiro-inositol ratio at the full 4,000 mg MI dose used in clinical research, split across two daily servings. The powdered sachet format supports consistent twice-daily dosing without counting capsules, and Theralogix's pharmaceutical-grade manufacturing standards are consistently cited in the product's peer-reviewed applications. For women who prioritize formulation integrity above cost, this is the benchmark product in the category.

Pros

NSF Certified third-party testing provides independent verification of label claims and purity

Delivers the clinically studied 40:1 myo:d-chiro-inositol ratio at 2,000 mg MI per serving (4,000 mg total daily dose)

Unflavored powder sachets dissolve easily in water or juice and support consistent twice-daily compliance

Cons

At $52.99 per box, the price per serving is the highest of the three reviewed products, which may be a barrier for long-term consistent use

Trust Context

No active FDA recall foundNo tainted-supplement match found

Evidence

Limited evidencescore 10composite 15

Buy Ovasitol Inositol Supplement$52.99

#2 Runner-Up

8.4

Wholesome Story

Myo-Inositol & D-Chiro by Wholesome Story

4.5

$24.99/ $0.42 per serving

Wholesome Story's combination product ranks second by offering the 40:1 ratio in a capsule format at a price point that is less than half of the top-ranked product. For women who prefer capsules over powder or for whom cost is a meaningful factor in long-term adherence, this formulation represents a reasonable middle ground. The product does not carry NSF certification, which is a meaningful limitation relative to Ovasitol, and the total daily dose delivered depends on adherence to the full recommended serving. Nonetheless, the high review volume and consistent ratings suggest reliable formulation quality for a budget-conscious option.

Pros

40:1 myo-inositol to d-chiro-inositol ratio aligns with the physiological target supported by clinical research

Capsule format appeals to women who prefer discrete dosing over mixing powder into beverages

Price per serving at $0.42 makes long-term supplementation more financially accessible than premium alternatives

Cons

Lacks NSF or USP third-party certification, meaning label accuracy and purity have not been independently verified to the same standard as Ovasitol

Trust Context

No active FDA recall foundNo tainted-supplement match found

Evidence

Limited evidencescore 10composite 27.2

Buy Myo-Inositol & D-Chiro by Wholesome Story$24.99

#3 Also Great

7.9

Fairhaven Health

Fairhaven Health Myo-Plus

4.4

$29.99/ $0.5 per serving

Fairhaven Health has established credibility in the women's reproductive health supplement space, and Myo-Plus reflects that positioning. The product is designed specifically for women with PCOS and fertility concerns and delivers myo-inositol alongside supportive cofactors including folic acid, which has independent relevance for women of reproductive age. The formulation's ratio and total myo-inositol dose per serving should be confirmed against the current label, as formulations can change. The product ranks third because its review count is lower and third-party certification status is less clearly established than the top two, but it remains a viable option particularly for women who want cofactor support within a single product.

Pros

Brand specialization in reproductive health supplements suggests category expertise and product development focus relevant to PCOS

Includes folic acid, which is independently recommended for women of reproductive age and adds value beyond inositol alone

Mid-range price per serving at $0.50 balances cost and quality positioning between the top two options

Cons

Third-party certification status is not as clearly documented as Ovasitol, and users should verify current label details before purchase

Trust Context

No active FDA recall foundNo tainted-supplement match found

Evidence

Limited evidencescore 10composite 25.2

Buy Fairhaven Health Myo-Plus$29.99

Free Buyer Guide

Compare supplements with the same checklist we use.

Get the anti-aging supplement cheat sheet with evidence prompts, safety checks, and label-quality questions before you buy.

Get the guide

Side-by-Side

Comparison Table

Category	#1 Ovasitol Inositol Supplement Theralogix	#2 Myo-Inositol & D-Chiro by Wholesome Story Wholesome Story	#3 Fairhaven Health Myo-Plus Fairhaven Health
Score	8.8/10	8.4/10	7.9/10
Best For
Pros	NSF Certified third-party testing provides independent verification of label claims and purity Delivers the clinically studied 40:1 myo:d-chiro-inositol ratio at 2,000 mg MI per serving (4,000 mg total daily dose)	40:1 myo-inositol to d-chiro-inositol ratio aligns with the physiological target supported by clinical research Capsule format appeals to women who prefer discrete dosing over mixing powder into beverages	Brand specialization in reproductive health supplements suggests category expertise and product development focus relevant to PCOS Includes folic acid, which is independently recommended for women of reproductive age and adds value beyond inositol alone
Cons	At $52.99 per box, the price per serving is the highest of the three reviewed products, which may be a barrier for long-term consistent use	Lacks NSF or USP third-party certification, meaning label accuracy and purity have not been independently verified to the same standard as Ovasitol	Third-party certification status is not as clearly documented as Ovasitol, and users should verify current label details before purchase

The Science

How Myo-Inositol Supports PCOS Support

Myo-inositol belongs to the B-vitamin family of compounds and functions as a structural component of cell membrane phospholipids, but its relevance to PCOS is primarily as a second messenger in intracellular signaling. When insulin binds its receptor at the cell surface, a cascade of downstream signals is triggered inside the cell. A critical component of this cascade involves inositol phosphoglycans — molecules synthesized from inositol — that act as mediators conveying the insulin signal to intracellular targets including glucose transporter proteins. In women with PCOS, a defect has been proposed at the level of this inositol-mediated signaling pathway. The hypothesis, supported by a number of investigations, is that inadequate conversion of myo-inositol to d-chiro-inositol within insulin-sensitive tissues impairs the DCI-dependent arm of insulin signaling, contributing to the insulin resistance that characterizes the metabolic phenotype of PCOS in many women. At the same time, excessive conversion in certain tissues — specifically the ovarian follicle — may impair FSH signaling and oocyte quality, which is why supplementing d-chiro-inositol alone at high doses is not necessarily beneficial and may be counterproductive. The 40:1 myo-inositol to d-chiro-inositol ratio reflects an attempt to approximate the physiological concentrations found in healthy human follicular fluid and plasma. By providing predominantly myo-inositol alongside a smaller quantity of DCI, the combination may support both the insulin-sensitizing functions of the DCI-mediated pathway and the FSH-signaling functions that depend on adequate myo-inositol availability in ovarian tissue. Myo-inositol also participates in signaling through the FSH receptor directly, and adequate ovarian MI concentrations appear important for follicular development and oocyte maturation. This mechanistic duality is why formulation specificity matters more for PCOS than for many other supplement applications.

Buying Guide

What to Look For When Buying Myo-Inositol

Dosage

Dosage Guidance

The dosage used most consistently in clinical research on myo-inositol for PCOS is 4,000 mg of myo-inositol per day, typically divided into two 2,000 mg doses taken morning and evening. When using a 40:1 ratio combination product, this translates to approximately 100 mg of d-chiro-inositol per day alongside the 4,000 mg of myo-inositol. Most researchers and clinicians working in this area suggest this divided dosing approach because it may better sustain consistent tissue-level concentrations throughout the day compared to a single larger dose. Timing relative to meals does not appear to be a critical variable in the available literature, though some practitioners suggest taking doses with food to minimize the mild gastrointestinal discomfort that some individuals experience, particularly when first starting supplementation. Powder forms such as sachet-based products can be mixed into water, juice, or a smoothie, which may also help tolerability. For women who are taking myo-inositol as part of a fertility-focused protocol, it is important to note that meaningful changes in ovulation frequency and hormonal markers in research trials typically emerged after a minimum of three months of consistent use, and many studies ran for six months. Expecting rapid results within days or a few weeks is not well supported by the evidence. Dosage adjustments may be appropriate in certain circumstances, and no supplement dosing decision should be finalized without input from a qualified healthcare provider who is familiar with your complete medical history, current medications, and lab values. This guidance reflects research-derived ranges and is not a prescription.

Always follow your healthcare provider's recommendations. Dosages vary by individual health status, age, and goals.

What Users Complain About

Common Myo-Inositol Complaints (And How to Avoid Them)

Based on analysis of thousands of customer reviews across Myo-Inositol products.

Safety

Safety & Interactions

Myo-inositol has a well-established safety profile across a large number of studies and is generally well tolerated at the doses used for PCOS support. The most commonly reported adverse effects are gastrointestinal and mild: nausea, bloating, flatulence, and loose stools, particularly at the start of supplementation. These effects tend to diminish after the first one to two weeks as the body adjusts. Starting at a lower dose and gradually increasing to the full 4,000 mg daily target may reduce the likelihood of initial GI discomfort. Myo-inositol does not appear to carry significant drug interaction risks in the published literature, but interactions with certain medications cannot be entirely excluded, particularly for women taking insulin, metformin, or other agents that affect insulin sensitivity or glucose metabolism. Because myo-inositol and metformin both exert insulin-sensitizing effects, concurrent use could theoretically amplify hypoglycemic effects, and this warrants monitoring and physician guidance. Women on antidepressants, particularly SSRIs, should also discuss supplementation with their prescriber, as inositol has been investigated — in different doses — for mood-related conditions. Products should be sourced from manufacturers with third-party testing certifications where possible, as the supplement industry is not subject to the same pre-market approval requirements as pharmaceuticals in the United States. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician or a qualified healthcare provider before beginning any new supplement regimen, particularly if you have a diagnosed medical condition or are taking prescription medications.

Standard safety disclaimers

Pregnancy and breastfeeding: Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women.
Blood thinners: If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects.
Kidney disease: If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced.
Gout: Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.

"
"As a registered nutritionist-dietitian, I want to emphasize that myo-inositol — particularly in the 40:1 combination with d-chiro-inositol — is one of the more evidence-supported nutraceutical options for women navigating the metabolic dimensions of PCOS. The research is genuinely encouraging, but I encourage realistic expectations: this is a supportive intervention, not a standalone treatment, and it works best as part of a comprehensive approach that includes appropriate dietary patterns, physical activity, and ongoing monitoring by your healthcare team. Women who are also managing thyroid conditions, which are disproportionately common in PCOS, should ensure those are optimally managed before attributing symptom persistence to any single supplement gap. Give any inositol protocol a minimum of three months before evaluating whether it is contributing meaningfully to your goals, and always loop in your physician or dietitian to track relevant lab markers over time."
— Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950

Common Questions

Frequently Asked Questions

Based on the available evidence and formulation criteria, Theralogix Ovasitol is the most defensible choice for women with PCOS who are prioritizing formulation quality and third-party verification. It delivers the 40:1 myo-inositol to d-chiro-inositol ratio at the 4,000 mg total daily dose that appears most frequently in clinical research, in a powder sachet format that supports twice-daily dosing, and it is NSF Certified — a meaningful distinction in a supplement category where label accuracy is not regulated pre-market. For women where cost is a significant barrier to consistent long-term use, Wholesome Story's combination product offers the same 40:1 ratio at roughly half the price per serving, with the trade-off that it lacks equivalent third-party certification. The 'best' product ultimately depends on your individual priorities, and any selection should be discussed with a healthcare provider who knows your complete health profile.

This is one of the most important expectation-setting questions for women considering myo-inositol supplementation, and the honest answer is that meaningful changes — if they occur — generally emerge over a timeframe of three to six months of consistent use, not days or weeks. Clinical trials examining menstrual cycle regularity typically run for a minimum of three months before assessing outcomes, and many of the studies showing the most notable improvements in androgen levels and ovulation rates were conducted over six months. Women sometimes report noticing changes in cycle regularity or energy levels earlier, but these observations in individual users cannot be separated from placebo effects or natural variation in PCOS symptom expression. Consistency of dosing matters: benefits seen in research reflect twice-daily dosing at the full 4,000 mg target. Intermittent use or doses substantially below this threshold are unlikely to replicate research outcomes. Please discuss a realistic timeline and monitoring plan with your physician or registered dietitian-nutritionist.

The dose most consistently used in clinical research on PCOS is 4,000 mg of myo-inositol per day, divided into two 2,000 mg doses taken morning and evening. When using a 40:1 combination product, this daily myo-inositol intake is accompanied by approximately 100 mg of d-chiro-inositol. This divided dosing approach is thought to better maintain consistent tissue-level availability compared to a single large daily dose. It is worth noting that some earlier research used myo-inositol alone without d-chiro-inositol, and a separate body of literature examined d-chiro-inositol alone at lower doses. The 40:1 combination at 4,000 mg MI represents the most current consensus from research groups specializing in inositol and PCOS. Doses above 4,000 mg MI per day do not appear to offer additional benefit in available trials and may increase GI side effects. These are research-derived ranges, not a clinical prescription, and dosing decisions should be made in consultation with your healthcare provider.

Myo-inositol is generally well tolerated, and its adverse effect profile is mild compared to pharmaceutical interventions for PCOS. The most commonly reported side effects are gastrointestinal: nausea, bloating, flatulence, and occasionally loose stools, particularly in the first one to two weeks of supplementation. Starting at a lower dose and gradually titrating up, and taking doses with food, can reduce the likelihood of these effects. Regarding drug interactions, the most clinically relevant concern involves medications that affect blood glucose or insulin sensitivity. Women taking metformin, insulin, or other antidiabetic agents should consult their prescribing physician before adding myo-inositol, as the combined insulin-sensitizing effect could theoretically increase the risk of hypoglycemia and may warrant dose adjustments or closer blood glucose monitoring. Some clinicians also recommend discussing supplementation with a prescriber if taking SSRIs, as inositol has been investigated in mood-related conditions and its interaction with these medications, while not well characterized at PCOS doses, warrants awareness. Always disclose all supplements to your healthcare team.

While myo-inositol is considered safe for most healthy adults, several populations should exercise caution or avoid use without explicit medical clearance. Pregnant women should not begin supplementation without discussing it with their OB-GYN, as evidence in pregnancy is not comprehensive across all trimesters. Women with diagnosed bipolar disorder should consult a psychiatrist first, as inositol has been investigated at higher doses for mood disorders and the theoretical implications for mood signaling warrant professional review. Individuals with kidney disease or significantly impaired renal function should consult a nephrologist, as renal handling of inositol may be altered. Women currently managing type 2 diabetes with prescription medications — including metformin, insulin secretagogues, SGLT2 inhibitors, or GLP-1 receptor agonists — should discuss supplementation with their prescribing physician to evaluate the combined insulin-sensitizing effect and establish a monitoring plan. Women with a documented history of recurrent hypoglycemia should also seek medical guidance before starting. These cautions do not imply myo-inositol is dangerous for these groups, but they reflect the principle that supplementation decisions in complex clinical contexts require individualized professional oversight.

Scientific References

Citations & Research

This page references peer-reviewed research indexed on PubMed/NCBI. Citations are provided for transparency. Always consult a qualified healthcare professional before making any medical decisions.

[1]Nordio M et al.. “The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios..” European review for medical and pharmacological sciences, 2019. doi:10.26355/eurrev_201906_18223 PMID 31298405 ↗
[2]Kamenov Z et al.. “Inositols in PCOS..” Molecules (Basel, Switzerland), 2020. doi:10.3390/molecules25235566 PMID 33260918 ↗
[3]Morley LC et al.. “Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility..” The Cochrane database of systematic reviews, 2017. doi:10.1002/14651858.CD003053.pub6 PMID 29183107 ↗
[4]Gul M et al.. “Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial..” Naunyn-Schmiedeberg's archives of pharmacology, 2025. doi:10.1007/s00210-025-03813-9 PMID 39847053 ↗
[5]Regidor PA et al.. “Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature..” Hormone molecular biology and clinical investigation, 2018. doi:10.1515/hmbci-2017-0067 PMID 29498933 ↗

Ready to Try Myo-Inositol?

Our top pick for pcos support. Third-party tested, highly reviewed.

Shop #1 Pick — Ovasitol Inositol Supplement

Affiliate link — we may earn a commission at no extra cost to you

Continue exploring

our full Myo Inositol reviewSupplement overview
pcos support — supplements that may helpGoal overview
Alpha Lipoic Acid for pcos supportAlternative supplement
how we rate Berberine for pcos supportAlternative supplement
Myo Inositol for anxiety reliefSame supplement, different goal
our top Inositol pick for pcos supportEditor pick
Chromium and pcos support: what to knowEditor pick